Literature DB >> 24185813

Are nicotinic acetylcholine receptors coupled to G proteins?

Nadine Kabbani, Jacob C Nordman, Brian A Corgiat, Daniel P Veltri, Amarda Shehu, Victoria A Seymour, David J Adams.   

Abstract

It was, until recently, accepted that the two classes of acetylcholine (ACh) receptors are distinct in an important sense: muscarinic ACh receptors signal via heterotrimeric GTP binding proteins (G proteins), whereas nicotinic ACh receptors (nAChRs) open to allow flux of Na+, Ca2+, and K+ ions into the cell after activation. Here we present evidence of direct coupling between G proteins and nAChRs in neurons. Based on proteomic, biophysical, and functional evidence, we hypothesize that binding to G proteins modulates the activity and signaling of nAChRs in cells. It is important to note that while this hypothesis is new for the nAChR, it is consistent with known interactions between G proteins and structurally related ligand-gated ion channels. Therefore, it underscores an evolutionarily conserved metabotropic mechanism of G protein signaling via nAChR channels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24185813     DOI: 10.1002/bies.201300082

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  35 in total

1.  Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.

Authors:  Nicole A Horenstein; Roger L Papke; Abhijit R Kulkarni; Ganesh U Chaturbhuj; Clare Stokes; Khan Manther; Ganesh A Thakur
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

2.  Microtubule dynamics at the growth cone are mediated by α7 nicotinic receptor activation of a Gαq and IP3 receptor pathway.

Authors:  Jacob C Nordman; Nadine Kabbani
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

3.  Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ2 -Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation.

Authors:  Marta Quadri; Carlo Matera; Almin Silnović; Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Roger L Papke; Clelia Dallanoce
Journal:  ChemMedChem       Date:  2017-06-12       Impact factor: 3.466

Review 4.  Looking below the surface of nicotinic acetylcholine receptors.

Authors:  Clare Stokes; Millet Treinin; Roger L Papke
Journal:  Trends Pharmacol Sci       Date:  2015-06-08       Impact factor: 14.819

Review 5.  Molecular function of α7 nicotinic receptors as drug targets.

Authors:  Cecilia Bouzat; Matías Lasala; Beatriz Elizabeth Nielsen; Jeremías Corradi; María Del Carmen Esandi
Journal:  J Physiol       Date:  2017-11-29       Impact factor: 5.182

6.  Molecular function of the novel α7β2 nicotinic receptor.

Authors:  Beatriz E Nielsen; Teresa Minguez; Isabel Bermudez; Cecilia Bouzat
Journal:  Cell Mol Life Sci       Date:  2018-01-08       Impact factor: 9.261

7.  Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.

Authors:  Sita Nirupama Nishtala; Nelli Mnatsakanyan; Akash Pandhare; Chun Leung; Michaela Jansen
Journal:  J Neurochem       Date:  2016-03-11       Impact factor: 5.372

Review 8.  Merging old and new perspectives on nicotinic acetylcholine receptors.

Authors:  Roger L Papke
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

9.  A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries.

Authors:  Matías Lasala; Jeremías Corradi; Ariana Bruzzone; María Del Carmen Esandi; Cecilia Bouzat
Journal:  J Biol Chem       Date:  2018-05-21       Impact factor: 5.157

10.  The minimal pharmacophore for silent agonism of the α7 nicotinic acetylcholine receptor.

Authors:  Roger L Papke; Kinga Chojnacka; Nicole A Horenstein
Journal:  J Pharmacol Exp Ther       Date:  2014-07-02       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.